VectivBio Holding AG
VECT · NASDAQ
12/31/2022 | 6/30/2022 | 12/31/2021 | 6/30/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $27 | $0 | $0 |
| % Growth | -97.5% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $27 | $0 | $0 |
| % Margin | 100% | 100% | – | – |
| R&D Expenses | -$112 | $186 | $25 | $25 |
| G&A Expenses | $7 | $27 | $18 | $18 |
| SG&A Expenses | $7 | $27 | $18 | $18 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $64 | -$64 | -$86 | -$86 |
| Operating Expenses | -$40 | $148 | -$43 | -$43 |
| Operating Income | -$29 | -$52 | -$43 | -$43 |
| % Margin | -4,223.9% | -194.9% | – | – |
| Other Income/Exp. Net | -$94 | $81 | -$0 | -$0 |
| Pre-Tax Income | -$29 | -$65 | -$43 | -$43 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$28 | -$65 | -$44 | -$44 |
| % Margin | -4,212.8% | -244.7% | – | – |
| EPS | -0.65 | -1.47 | -1.62 | -1.62 |
| % Growth | 55.8% | 9.3% | 0% | – |
| EPS Diluted | -0.65 | -1.47 | -1.62 | -1.62 |
| Weighted Avg Shares Out | 44 | 44 | 27 | 27 |
| Weighted Avg Shares Out Dil | 44 | 44 | 27 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $0 |
| Interest Expense | -$0 | $3 | $0 | $0 |
| Depreciation & Amortization | -$0 | $1 | $0 | $0 |
| EBITDA | -$29 | -$51 | -$43 | -$43 |
| % Margin | -4,236.8% | -192% | – | – |